Navigation Links
NxStage to Present at the UBS Global Life Sciences Conference
Date:9/1/2009

LAWRENCE, Mass., Sept. 1 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, and Robert Brown, Chief Financial Officer, will be presenting at the UBS Global Life Sciences Conference on Tuesday, September 22, 2009 at the Grand Hyatt, Grand Central in New York City.

NxStage's investor presentation is scheduled for Tuesday, September 22nd at 4:00 p.m. (EST). To listen to the audio webcast of the presentation during the event, please visit: http://www.nxstage.com and click on 'Investor Information'.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. E
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. NxStage to Present at the Canaccord Adams Global Growth Conference
2. NxStage(R) Announces Extension of Medisystems Needle Supply and Distribution Agreement
3. NxStage to Report Second Quarter 2009 Financial Results
4. NxStage(R) Announces Medisystems(R) Bloodline Distribution Agreement with Gambro
5. NxStage Announces Closing of $40 Million Debt Financing with Asahi Kasei Kuraray Medical
6. NxStage to Present at the William Blair Growth Stock Conference
7. NxStage Extends Supply Agreement with B. Braun Medical Inc. to Include Streamline(R) Technology
8. NxStage Announces Strategic Business Alliance with Asahi Kasei Kuraray Medical
9. NxStage Ranked Fourth Largest Revenue Gaining Company in Massachusetts for 2008
10. NxStage to Present at the Canaccord Adams Diabetes & Obesity Conference
11. NxStage Announces Credit Facility Amendment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 2014 The Mesothelioma Applied Research ... International Symposium on Malignant Mesothelioma from March 2nd through ... sessions will take place on the campus of the ... a community dinner and an awards ceremony, will be ... cover a range of topics about pleural and peritoneal ...
(Date:11/24/2014)... UK (PRWEB) November 24, 2014 ... Massaggi , London's pre-eminent pain-relief service and massage ... Emmett Sports Massage (ESM). This newest sports ... , The key difference between traditional sports massage ... to access the body's very own "reset button,” ...
(Date:11/24/2014)... SWAccessControl.com has recently released a new collection ... the company is a leading online supplier in the international ... available at discounted prices, up to 30% off. , “We ... This time, all of our items are offered at low ... so I have confidence in our fresh assortment. You will ...
(Date:11/24/2014)... Philadelphia, PA (PRWEB) November 24, 2014 ... care coordination and disease management services to health ... to implement Essette’s Medical Management software suite. ... SaaS platform in a program to reduce patients' ... includes Population Health Management, Care Management, Utilization Management, ...
(Date:11/23/2014)... 24, 2014 The clinical trial ... provides data on the Aspergillosis clinical trial scenario. ... to the clinical trials on Aspergillosis. It includes ... recruitment status as per the site of trial ... preliminary coverage of disease clinical trials by their ...
Breaking Medicine News(10 mins):Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 2Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 3Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 3Health News:SWAccessControl.com Is Happy To Release New Range Of Magnetic Locks 2Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4
... March 7 The rheumatoid arthritis (RA),treatment market, held ... withdrawal of Vioxx and Bextra, is rebounding due to ... to,treat RA topped $12 billion in 2006 and -- ... over 11% a year through 2011,according to a new ...
... March 7 Universal,Health Realty Income Trust (NYSE: ... of,Trustees voted to pay a dividend of $.58 ... record as of March 17, 2008., Universal ... trust,invests in healthcare and human service related facilities ...
... research and teaching at ... the Medical Center, COLUMBUS, Ohio, ... over the last six years accounting,for nearly 50 percent of the region,s ... employers reduced jobs, says an economic,impact report released today by the Columbus ...
... Va.--Dr. X.J. Meng, of Blacksburg, Va., a professor of ... Department of Biomedical Sciences and Pathobiology at Virginia Tech, ... million from the National Institutes of Health (NIH) to ... of the work is to develop a vaccine to ...
... on a cells ability to roll along a surface, MIT ... kinds of cells a process that could result in ... in remote locations. , Rohit Karnik, an MIT assistant professor ... the new finding appearing this week in the journal Nano ...
... of developmental neurobiology at the Medical College of Georgia ... received the 2008 Mathilde Solowey Lecture Award in Neurosciences. ... Advanced Education in the Sciences, honors young or rising ... translational and of broad importance. , Dr. Mei will ...
Cached Medicine News:Health News:In Post-Vioxx Era, Biologics are Reviving the Arthritis Treatment Market 2Health News:Chamber Analysis Shows OSU Medical Center Leads Area Job Growth 2Health News:Chamber Analysis Shows OSU Medical Center Leads Area Job Growth 3Health News:Human, animal vaccine development goal of hepatitis E virus research 2Health News:Human, animal vaccine development goal of hepatitis E virus research 3Health News:On a 'roll': MIT researchers devise new cell-sorting system 2Health News:Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences 2Health News:Dr. Mei receives 2008 Mathilde Solowey Lecture Award in Neurosciences 3
(Date:11/23/2014)... , Nov. 23, 2014  Aurobindo Pharma ... of Gabapentin Capsules, USP 300 mg 100-count bottles to ... to contain some empty capsules. Empty capsules ... adverse health consequences that could range from no effect, ... or status epilepticus (long period seizures) that could be ...
(Date:11/22/2014)... -- New data demonstrates that flibanserin, a novel, non-hormonal medicine ... sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), does not ... women when taken at bedtime. The data was presented ... America,s (SMSNA) 20th Annual Fall Scientific Meeting ... SMSNA accepted this study as a late breaking abstract ...
(Date:11/22/2014)... , 21 de noviembre de 2014  BioClinica®, ... clínicos externalizados y tecnologías eClinical, ha indicado un ... ,seguimiento inteligente, para el seguimiento basado en el ... amplía el concepto del seguimiento basado en el ... las visitas de seguimiento o cambio de los ...
Breaking Medicine Technology:Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3
... Today Novo Nordisk announced results of its ... treatment with NovoLog® (insulin aspart [rDNA origin] injection). The ... Scientific Sessions, demonstrated a reduction of A1c levels in ... was introduced at meals, using two approaches that start ...
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Global Melanoma Therapeutics industry , ... http://www.reportlinker.com/p0197206/Global-Melanoma-Therapeutics-industry.html , , , ... markets for Melanoma Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, ...
Cached Medicine Technology:Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients 2Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients 3Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients 4Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients 5Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients 6Global Melanoma Therapeutics Industry 2Global Melanoma Therapeutics Industry 3Global Melanoma Therapeutics Industry 4Global Melanoma Therapeutics Industry 5Global Melanoma Therapeutics Industry 6Global Melanoma Therapeutics Industry 7Global Melanoma Therapeutics Industry 8Global Melanoma Therapeutics Industry 9Global Melanoma Therapeutics Industry 10Global Melanoma Therapeutics Industry 11Global Melanoma Therapeutics Industry 12
... for the precise requirements of blood ... Blood Bank Equipment meets American Association ... Red Cross (ANRC) and U.S. Food ... storage freezers, and platelet incubators feature ...
... Designed for the precise requirements ... Thermo Forma Blood Bank Equipment meets ... American National Red Cross (ANRC) and ... standards. Refrigerators, storage freezers, and platelet ...
Refrigerator specially designed for the storage of blood in standard 500ml bags, complying with Australian Standard AS3864 1997....
The Testosterone Enzyme Immunoassay is intended for the quantitative determination of Testosterone concentration in human serum. No special pretreatment of the sample is necessary. For in vitro Diag...
Medicine Products: